rs201437896
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_001024845.3(SLC6A9):c.832C>T(p.Gln278*) variant causes a stop gained change. The variant allele was found at a frequency of 0.0000198 in 1,461,868 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001024845.3 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC6A9 | NM_001024845.3 | c.832C>T | p.Gln278* | stop_gained | Exon 7 of 14 | ENST00000372310.8 | NP_001020016.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 251470Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135908
GnomAD4 exome AF: 0.0000198 AC: 29AN: 1461868Hom.: 0 Cov.: 33 AF XY: 0.0000193 AC XY: 14AN XY: 727234
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Atypical glycine encephalopathy Pathogenic:1
This sequence change creates a premature translational stop signal (p.Gln351*) in the SLC6A9 gene. It is expected to result in an absent or disrupted protein product. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals with SLC6A9-related disease. Loss-of-function variants in SLC6A9 are known to be pathogenic (PMID: 27773429). For these reasons, this variant has been classified as Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at